Promo video 60 sec
  Bosnalijek in short
  Mision and vision
  Corporate responsibility
  Quality policy
  Bosnalijek worldwide

Jukićeva 53
71000 Sarajevo
Bosna i Hercegovina

tel. +387(0)33 254 400
fax. +387(0)33 814 253


Leading pharmaceutical company in Bosnia and Herzegovina

Bosnalijek d.d. (Bosnalijek), the largest drug producer in Bosnia and Herzegovina, has been established in 1951. Its products are exported to three continents.

A diversified manufacturing programme encompasses 170 medicines, based on 105 different generic names. In addition to medicines, the manufacturing programme consists of 7 food supplements, three disinfectants for medicinal use and four disinfectants for wide consumption.

The structure of manufacturing programme is focused on medicines that belong to mass therapeutic use. Those are medicines for peroral, parenteral and topical use with an effect on digestive system and metabolism, cardiovascular system, systemic infections, skin, skeletomuscular, nervous and respiratory system, as well as systemic hormone medications with the exception of sex hormones.

In line with permanently being user-oriented, Bosnalijek launched 85 percent of its manufacturing programme in the last two decades, which is adapted to users' needs.

Our strategic orientation is directed towards improving the quality of our business and manufacturing processes. Therefore, a continuous improvement, careful analysis and careful planning are the basic principles of our operations.

Bosnalijek is among the leading companies in the local market, and 65 percent of the total sales income is achieved in export markets, being a confirmation of a strong internationalisation of business operations.

Our products are sold in markets of Bosnia and Herzegovina, Croatia, Serbia, Montenegro, Kosovo, Macedonia, Albania, Russia, Ukraine, Moldova, Georgia, Azerbaijan, Armenia and Kazakhstan. The quality and efficacy of each new medicine is confirmed with a registration certificate, or marketing authorisation for an individual pharmaceutical market. The number of registered Bosnalijek’s products in export, 336, directly indicates their quality, effectiveness and efficacy.

The foundations of Bosnalijek's development are facility modernization, personnel training and professional development, as well as harmonisation of business with world pharmaceutical standards, where around 125 million KM has been invested over the last 20 years.

A modern Development Centre, covering an area of 1842 m2, is equipped with modern laboratories run by top pharmaceutical experts with internationally acquired scientific titles. We have been continuously adopting new technologies and by having introduced the SAP IT system, we have completely automatized our business operations.

At the end of 2015, a total of 792 persons were employed in Bosnalijek, of whom 46 percent were university graduates, specialists, held master’s degree or doctoral degree.

In its decade-long business, Bosnalijek has been committed to consistent quality implementation in all business operations and processes. It is in this way that it manufactures top quality medicines and ranks among internationally competent pharmaceutical companies.

Bosnalijek's quality system is fully compliant with national and international regulations and Good Manufacturing Practice standards, which justifies the expectations of users, partners and regulatory authorities.

The key foundation of Bosnalijek's success and business policy is an integrated management system which in addition to Good Manufacturing Practice requirements, also covers the requirements of ISO 9001, ISO 14001 and OHSAS 18001 standards.

Bosnalijek expresses its interest and care for development of BiH society on a daily basis by supporting projects and manifestations in the fields of culture, sports, science and education.

We especially support education and successfully cooperate with pharmaceutical and medical faculties as well as faculties of natural sciences and mathematics through sponsoring the work of young and talented students as well as scientific achievements in medical and pharmaceutical fields. We intensively support professional and scientific conferences as well as the participating of BiH experts at international conferences.

Due to the way the Company integrates care for the society and environment in its work, Bosnalijek was awarded first prize for "Socially responsible company in 2008 in BiH” by organisation Mozaik.

Our success is the result of a well-thought-out strategy and a totality of joint efforts to develop the company so as to become a renowned and recognized manufacturer. Thanks to its business orientation, whose imperative is excellence, Bosnalijek has been cooperating with world-renowned pharmaceutical companies such as: Eli Lilly, Hoffman-La Roche, Jordanian Pharmaceutical Manufacturing Co. and others.


home | RSS | contacts |
about us | products | investors | press center | career | factory tour

Copyright © 2008 - All rights reserved
design and development DWS and DSD May 2008

Royal Jelly